Protein name:
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha ;
Alternative:
FTase-alpha ;CAAX farnesyltransferase subunit alpha ;Type I protein geranyl-geranyltransferase subunit alpha (GGTase-I-alpha) ;Ras proteins prenyltransferase subunit alpha ;
Organism:
Human (Homo sapiens).
General Annotation
Sub Unit:
Heterodimer of an alpha and a beta subunit.
Function:
Catalyzes the transfer of a farnesyl or geranyl-geranyl moiety from farnesyl or geranyl-geranyl pyrophosphate to a cysteine at the fourth position from the C-terminus of several proteins having the C-terminal sequence Cys-aliphatic-aliphatic-X. The alpha subunit is thought to participate in a stable complex with the substrate. The beta subunit binds the peptide substrate.
Subcellular Location:
N/A
Protein Attributes:
50:
MAATEGVGEA | AQGGEPGQPA | QPPPQPHPPP | PQQQHKEEMA | AEAGEAVASP |
100:
MDDGFVSLDS | PSYVLYRDRA | EWADIDPVPQ | NDGPNPVVQI | IYSDKFRDVY |
150:
DYFRAVLQRD | ERSERAFKLT | RDAIELNAAN | YTVWHFRRVL | LKSLQKDLHE |
200:
EMNYITAIIE | EQPKNYQVWH | HRRVLVEWLR | DPSQELEFIA | DILNQDAKNY |
250:
HAWQHRQWVI | QEFKLWDNEL | QYVDQLLKED | VRNNSVWNQR | YFVISNTTGY |
300:
NDRAVLEREV | QYTLEMIKLV | PHNESAWNYL | KGILQDRGLS | KYPNLLNQLL |
350:
DLQPSHSSPY | LIAFLVDIYE | DMLENQCDNK | EDILNKALEL | CEILAKEKDT |
379:
IRKEYWRYIG | RSLQSKHSTE | NDSPTNVQQ
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Rat
Bovine
Mouse
Human
ELISA Kit for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
ELISA Kit for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
ELISA Kit for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
ELISA Kit for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
CLIA Kit for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
CLIA Kit for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
CLIA Kit for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
CLIA Kit for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Polyclonal Antibody for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Polyclonal Antibody for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Polyclonal Antibody for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Polyclonal Antibody for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Monoclonal Antibody for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Monoclonal Antibody for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Monoclonal Antibody for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Monoclonal Antibody for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Protein for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Protein for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Protein for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Protein for Human Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
tissue :
Retina .
2.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);MUTAGENESIS OF LYS-164;FUNCTION;CATALYTIC ACTIVITY;SUBUNIT
3.
"Characterization of recombinant human farnesyl-protein transferase: cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferases."
Omer C.A.
,
Kral A.M.
,
Diehl R.E.
,
Prendergast G.C.
,
Powers S.
,
Allen C.M.
,
Gibbs J.B.
,
Kohl N.E.
Biochemistry32:5167-5176(1993)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);MUTAGENESIS OF ASN-199;CATALYTIC ACTIVITY;FUNCTION
tissue :
Placenta .
4.
"Cloning of human full-length CDSs in BD Creator(TM) system donor vector."
Kalnine N.
,
Chen X.
,
Rolfs A.
,
Halleck A.
,
Hines L.
,
Eisenstein S.
,
Koundinya M.
,
Raphael J.
,
Moreira D.
,
Kelley T.
,
LaBaer J.
,
Lin Y.
,
Phelan M.
,
Farmer A.
Submitted (2003-08) to the EMBL/GenBank/DDBJ databases
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
5.
"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T.
,
Suzuki Y.
,
Nishikawa T.
,
Otsuki T.
,
Sugiyama T.
,
Irie R.
,
Wakamatsu A.
,
Hayashi K.
,
Sato H.
,
Nagai K.
,
Kimura K.
,
Makita H.
,
Sekine M.
,
Obayashi M.
,
Nishi T.
,
Shibahara T.
,
Tanaka T.
,
Ishii S.
,
Yamamoto J.
,
Saito K.
,
Kawai Y.
,
Isono Y.
,
Nakamura Y.
,
Nagahari K.
,
Murakami K.
,
Yasuda T.
,
Iwayanagi T.
,
Wagatsuma M.
,
Shiratori A.
,
Sudo H.
,
Hosoiri T.
,
Kaku Y.
,
Kodaira H.
,
Kondo H.
,
Sugawara M.
,
Takahashi M.
,
Kanda K.
,
Yokoi T.
,
Furuya T.
,
Kikkawa E.
,
Omura Y.
,
Abe K.
,
Kamihara K.
,
Katsuta N.
,
Sato K.
,
Tanikawa M.
,
Yamazaki M.
,
Ninomiya K.
,
Ishibashi T.
,
Yamashita H.
,
Murakawa K.
,
Fujimori K.
,
Tanai H.
,
Kimata M.
,
Watanabe M.
,
Hiraoka S.
,
Chiba Y.
,
Ishida S.
,
Ono Y.
,
Takiguchi S.
,
Watanabe S.
,
Yosida M.
,
Hotuta T.
,
Kusano J.
,
Kanehori K.
,
Takahashi-Fujii A.
,
Hara H.
,
Tanase T.-O.
,
Nomura Y.
,
Togiya S.
,
Komai F.
,
Hara R.
,
Takeuchi K.
,
Arita M.
,
Imose N.
,
Musashino K.
,
Yuuki H.
,
Oshima A.
,
Sasaki N.
,
Aotsuka S.
,
Yoshikawa Y.
,
Matsunawa H.
,
Ichihara T.
,
Shiohata N.
,
Sano S.
,
Moriya S.
,
Momiyama H.
,
Satoh N.
,
Takami S.
,
Terashima Y.
,
Suzuki O.
,
Nakagawa S.
,
Senoh A.
,
Mizoguchi H.
,
Goto Y.
,
Shimizu F.
,
Wakebe H.
,
Hishigaki H.
,
Watanabe T.
,
Sugiyama A.
,
Takemoto M.
,
Kawakami B.
,
Yamazaki M.
,
Watanabe K.
,
Kumagai A.
,
Itakura S.
,
Fukuzumi Y.
,
Fujimori Y.
,
Komiyama M.
,
Tashiro H.
,
Tanigami A.
,
Fujiwara T.
,
Ono T.
,
Yamada K.
,
Fujii Y.
,
Ozaki K.
,
Hirao M.
,
Ohmori Y.
,
Kawabata A.
,
Hikiji T.
,
Kobatake N.
,
Inagaki H.
,
Ikema Y.
,
Okamoto S.
,
Okitani R.
,
Kawakami T.
,
Noguchi S.
,
Itoh T.
,
Shigeta K.
,
Senba T.
,
Matsumura K.
,
Nakajima Y.
,
Mizuno T.
,
Morinaga M.
,
Sasaki M.
,
Togashi T.
,
Oyama M.
,
Hata H.
,
Watanabe M.
,
Komatsu T.
,
Mizushima-Sugano J.
,
Satoh T.
,
Shirai Y.
,
Takahashi Y.
,
Nakagawa K.
,
Okumura K.
,
Nagase T.
,
Nomura N.
,
Kikuchi H.
,
Masuho Y.
,
Yamashita R.
,
Nakai K.
,
Yada T.
,
Nakamura Y.
,
Ohara O.
,
Isogai T.
,
Sugano S.
more...
Nat. Genet.36:40-45(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
tissue :
Synovium .
6.
"DNA sequence and analysis of human chromosome 8."
Nusbaum C.
,
Mikkelsen T.S.
,
Zody M.C.
,
Asakawa S.
,
Taudien S.
,
Garber M.
,
Kodira C.D.
,
Schueler M.G.
,
Shimizu A.
,
Whittaker C.A.
,
Chang J.L.
,
Cuomo C.A.
,
Dewar K.
,
FitzGerald M.G.
,
Yang X.
,
Allen N.R.
,
Anderson S.
,
Asakawa T.
,
Blechschmidt K.
,
Bloom T.
,
Borowsky M.L.
,
Butler J.
,
Cook A.
,
Corum B.
,
DeArellano K.
,
DeCaprio D.
,
Dooley K.T.
,
Dorris L. III
,
Engels R.
,
Gloeckner G.
,
Hafez N.
,
Hagopian D.S.
,
Hall J.L.
,
Ishikawa S.K.
,
Jaffe D.B.
,
Kamat A.
,
Kudoh J.
,
Lehmann R.
,
Lokitsang T.
,
Macdonald P.
,
Major J.E.
,
Matthews C.D.
,
Mauceli E.
,
Menzel U.
,
Mihalev A.H.
,
Minoshima S.
,
Murayama Y.
,
Naylor J.W.
,
Nicol R.
,
Nguyen C.
,
O'Leary S.B.
,
O'Neill K.
,
Parker S.C.J.
,
Polley A.
,
Raymond C.K.
,
Reichwald K.
,
Rodriguez J.
,
Sasaki T.
,
Schilhabel M.
,
Siddiqui R.
,
Smith C.L.
,
Sneddon T.P.
,
Talamas J.A.
,
Tenzin P.
,
Topham K.
,
Venkataraman V.
,
Wen G.
,
Yamazaki S.
,
Young S.K.
,
Zeng Q.
,
Zimmer A.R.
,
Rosenthal A.
,
Birren B.W.
,
Platzer M.
,
Shimizu N.
,
Lander E.S.
more...
Nature439:331-335(2006)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
7.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
tissue :
Colon .
tissue :
Lung .
8.
"The full-ORF clone resource of the German cDNA consortium."
Bechtel S.
,
Rosenfelder H.
,
Duda A.
,
Schmidt C.P.
,
Ernst U.
,
Wellenreuther R.
,
Mehrle A.
,
Schuster C.
,
Bahr A.
,
Bloecker H.
,
Heubner D.
,
Hoerlein A.
,
Michel G.
,
Wedler H.
,
Koehrer K.
,
Ottenwaelder B.
,
Poustka A.
,
Wiemann S.
,
Schupp I.
more...
BMC Genomics8:399-399(2007)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 24-261 (ISOFORM 2)
9.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
tissue :
Cervix carcinoma .
10.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-373;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
tissue :
Cervix carcinoma .
11.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]
12.
"Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
Olsen J.V.
,
Vermeulen M.
,
Santamaria A.
,
Kumar C.
,
Miller M.L.
,
Jensen L.J.
,
Gnad F.
,
Cox J.
,
Jensen T.S.
,
Nigg E.A.
,
Brunak S.
,
Mann M.
Sci. Signal.3:RA3-RA3(2010)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-373;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
tissue :
Cervix carcinoma .
13.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
14.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
15.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH FNTB;SUBUNIT
16.
"3-aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency."
Bell I.M.
,
Gallicchio S.N.
,
Abrams M.
,
Beese L.S.
,
Beshore D.C.
,
Bhimnathwala H.
,
Bogusky M.J.
,
Buser C.A.
,
Culberson J.C.
,
Davide J.
,
Ellis-Hutchings M.
,
Fernandes C.
,
Gibbs J.B.
,
Graham S.L.
,
Hamilton K.A.
,
Hartman G.D.
,
Heimbrook D.C.
,
Homnick C.F.
,
Huber H.E.
,
Huff J.R.
,
Kassahun K.
,
Koblan K.S.
,
Kohl N.E.
,
Lobell R.B.
,
Lynch J.J. Jr.
,
Robinson R.
,
Rodrigues A.D.
,
Taylor J.S.
,
Walsh E.S.
,
Williams T.M.
,
Zartman C.B.
more...
J. Med. Chem.45:2388-2409(2002)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH FNTB;SUBUNIT;FUNCTION;CATALYTIC ACTIVITY
17.
"Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents."
deSolms S.J.
,
Ciccarone T.M.
,
MacTough S.C.
,
Shaw A.W.
,
Buser C.A.
,
Ellis-Hutchings M.
,
Fernandes C.
,
Hamilton K.A.
,
Huber H.E.
,
Kohl N.E.
,
Lobell R.B.
,
Robinson R.G.
,
Tsou N.N.
,
Walsh E.S.
,
Graham S.L.
,
Beese L.S.
,
Taylor J.S.
J. Med. Chem.46:2973-2984(2003)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH FNTB;SUBUNIT;FUNCTION;CATALYTIC ACTIVITY
18.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH FNTB;SUBUNIT
19.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH FNTB;SUBUNIT
20.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) IN COMPLEX WITH FNTB;FUNCTION;SUBUNIT;CATALYTIC ACTIVITY
21.
"Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase."
Hast M.A.
,
Fletcher S.
,
Cummings C.G.
,
Pusateri E.E.
,
Blaskovich M.A.
,
Rivas K.
,
Gelb M.H.
,
Van Voorhis W.C.
,
Sebti S.M.
,
Hamilton A.D.
,
Beese L.S.
Chem. Biol.16:181-192(2009)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 1-379 IN COMPLEX WITH FNTB;SUBUNIT;FUNCTION;CATALYTIC ACTIVITY